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o J# rtfJurt tIat diagnostic surgical patlwlo!J of two childrm wlw uruierwmt multiuisural abdorniMI 
transplantation and suruived for J month and 6 months. There is littll rtlevant liUraturt, and diagnostic 
,"./tria for tilt various clinical possibilitits art nol tstablishttl; this is mm1t mort complicattd by the 
simultantOus occurrmct of mort than ont proass. J# based our inltTpretations on conventiOMI histology, 
augmmttd with immunohistology, includiTI!J HLA staIning that distinguished graft from host ctlls in 
situ. In some instanm junctionlJl analysis of T cells propagauJ. from the same biopsies was available 
and was UStd to corroboratt morphological inJnprttaJions. A widt spectrum of cMnges was trlCounUrtd. 
GraJt·vtrsus-host distase, a prirtll concern before surgery, was Mt sun. Rejection was stvtrt in J patient, 
not pusmt in the other, and both Iuul evUlmet of lymphoproliferativt distast, which was rtlattd to 
Epsttin·Barr virus. Bacttrialt,anslocation through the gut wall was also aftaturt in both childrm. This 
paper documt7lts and iUustraUs tilt van'ous dilJtnostic possibilities. 
KEY OORDS iymplwprolif"aJuJt dutt1S<, inWtiov, lion, trQ7Upia1lJaJio1l, '9',lion. 
INTRODUCTION 
Multiple abdominal organ transplantation has been attempted, with even 
short-term survival, in only a limited number of children whose own small 
intestines were missing or irreversibly damaged and who had secondary liver 
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disease from the prolonged intravenous alimentation (1, 2). In addition to these 
previously described patients, another child subsequently underwent the same 
procedure at our institution, surviving for 37 days. During the 6 months that 
our first patient survived and the 5 weeks of the second, numerous biopsies of 
intestine, liver, lymphoid tissue, and skin were performed as part of the clinical 
diagnostic monitoring. Interpretation of some of the biological processes repre-
sented in the tissues was hampered at times by a lack of definitive criteria, by a 
dearth of prior experience in this or in similar clinical situations (3), and by the 
presence of more than one process at any particular time, each of which could 
be affected by the immunosuppressive therapy being administered. 
We reinforced our morphologic interpretations by using immunohisto-
chemistry that distinguished host from recipient cells and by using in-situ 
demonstration of lymphoid and viral markers. Although complete autopsies 
were denied in both instances, extensive postmortem sampling of the grafts 
was permitted. In this paper we set out to describe the morphology of the 
major processes observed in the grafted organs following multiple visceral 
transplantation in two children who survived for 912 and 37 days after opera-
tion. 
CLINICAL HISTORIES 
Case 1 
A 3 Ih-year-old black girl had a Christmas-tree deformity of the small 
intestine and lost all but 12.0 cm of proximal jejunum including the ileocecal 
junction and colon at 2 days of age. Intravenous hyperalimentation was insti-
tuted at age 5 months. Her growth was 5th percentile for height and 50th 
percentile for weight at 3112 years. Jaundice secondary to parenteral nutrition 
was progressive from the age of 2 years. At the time of surgery she was in 
frank liver failure, total bilirubin 27.5 mg/dl, serum albumin 2.0 g/dl, pro-
thrombin time 18.2 seconds, and aspartate aminotransferase level 303 U/L. 
The surgery, immune suppression, and clinical course have been reported in 
detail elsewhere (1). Briefly, the donor was a 2-month-old female who suffered 
a head injury. The graft consisted of stomach, small and large intestine, liver, 
and pancreas (Fig. 1). To deplete the graft of T cells and thus obviate graft-
versus-host disease, the donor was given 10 mg of OKT3 intravenously before 
removal of the graft, and the patient received 4.5 Gil of radiation to the 
abdomen. Immunosuppression was with cyclosporine A and prednisone and a 
I-week course of OKT3 was given from day 23 because of a clinical suspicion 
of rejection. Gram-negative bacteremia with &rratia marcescens and coagulase 
negative Staphylococcus aureus was documented on seven occasions during the 
first 12 days and was accompanied, on day 11, by bacterial cholangitis. 
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FIGURE I. The ",cipient operation of multivisceral transplantation. Note that the venous outflow of the 
graft was into a cloaca of the left and mIddle hepatic veiru. leaving the recipient vena cava intact. (A. donor 
aona; HA: hepatic anery; SA: splenic anery; LCA: left gastric anery; SMA: superior meswteric artery; 
IMA: inferior me5<:nteric anery; CDA: gastroduodenal anery.) 
Epstein-Barr virus (EBV) associated lymphoproliferative disease in the liver 
was diagnosed at 3 months after a relatively good clinical course, immune 
suppression was withdrawn, and the hepatic nodules regressed over the next 
month. After cyclosporine was restarted, a new hilar mass appeared that led 
to biliary obstruction, abscess formation, sepsis, and death. 
Case 2 
A Navajo girl developed secretory diarrhea a few days after birth. Paren-
teral hyperalimentation was instituted and despite chronic hospitalization her 
636 R. JAFFE ET AL. 
initial development was normal. At age 39 months she was admitted to Chil-
dren's Hospital of Pittsburgh where a diagnosis of microvillus inclusion dis-
ease was made (4). Because of progressive chronic liver disease from hyperali-
mentation she underwent multivisceral transplantation. 
In contrast to patient 1, the donor organs were not irradiated; the rest of 
the procedure was identical. Gastrointestinal continuity was restored by gas-
trogastrostomy and colocolostomy. Vascular connections were achieved by 
"piggyback" anastomosis of the donor aorta with its intact visceral branches 
onto the recipient aorta, and graft venous outflow was from the hepatic veins 
into the donor cava, which was interposed into the recipient vena cava. 
The donor was an 18-month-old male who suffered a lethal head injury 
7112 hours before organ removal. Cold ischemia time of the organs was 6 
hours and preservation was by the "slush technique" after infusion of UW 
solution (5). Intravenous cyclosporine and prednisone were started by the 
time of operation and azathioprine was given on postoperative days 2 and 3 
only. A 14-day course of OKT3 was begun on day 18. 
During the first few days Bacteroides thetaiotamicron was cultured from 
blood, pleural fluid, and abdominal drainage; coagulase-negative Staphylococ-
cus aUTtuS was cultured from blood on three occasions after the BactlToitks had 
been eradicated, but clinical infection was never a serious problem. Bilirubin 
rose from 2 mg/dl to 11.9 mg/dJ on day 18 and resolved promptly with the 
OKT3 administration. At the completion of the OKT3 cycle, the bilirubin 
rose once more, a capillary leak syndrome and progressive renal failure devel-
oped making fluid balance impossible, and she died on the 37th postoperative 
day. Biopsies had revealed a disseminated Iymphoproliferative disease on day 
33. 
In the 37 days of postoperative life, the patient was submitted to laparot-
omy five times for suspected perforation of a viscus, although none was found. 
An ileostomy was made on day 24 to permit closer monitoring. Autopsy per-
mission was refused, but extensive postmortem sampling of the graft was 
allowed. 
MATERIALS AND METHODS 
When sufficient quantities were available, biopsy (and postmortem) speci-
meDS were triaged for fixation in 10% neutral buffered formalin, snap-
freezing in optimum cutting temperature compound (OCT, Miles, Inc., 
Elkhart, IN), bacterial and viral cultures. At selected times, tissue from pa-
tieDt 2 was also placed in tissue culture medium supplemented with recombi-
nant interleukin-2 for selective expansion of graft-infiltrating lymphoid cells 
(6). Formalin-fixed, embedded bowel sections were exposed to an alkaline 
phosphatase substrate (Vector, Burlingame, California, Red #1) according to 
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the suggestion of Lake (7). Fixed tissues were stained with an avidin-biotin 
complex technique (ABC, Vector, Burlingame, California); the primary anti-
bodies used were rabbit polyclonal antibodies against immunoglobulin heavy 
and light chains, lysozyme, alpha-t-antichymotrypsin, and pancreatic peptide 
(DAKO, Santa Barbara, California). Monoclonal antibodies to cytomegalovi-
rus (Chemicon, El Segundo, California), B-cells (L-26) and some T-cells 
(UCH-I) (DAKO, Santa Barbara, California) were also used with appropri-
ate biological controls using the ABC method. Snap-frozen tissues were 
stained for the presence of lymphoid subset markers CD2, CD3, CD4, CD8; 
for IL-2 receptor (CD2S), HLA-DR and HLA-ABC, CD-14 for monocytes 
and CD20 for B-cells (Becton-Dickinson, Mountain View, California) anti-
kappa and anti-lambda light chains (DAKO, Santa Barbara, California) . 
For differentiating between donor and recipient cells in situ, monoclonal 
antibodies were used that had specificity against host and donor antigens, 
HLA-A3 versus Bw4 in Case 1; A25/32 and A24 versus Bw6 and A2 in Case 
2 (Karin Nelson, Ph.D" Genetic Systems, Seattle, Washington). These al-
loantigens were demonstrated using an alkaline-phosphatase, antialkaline 
phosphatase procedure (8) or by an ABC method (Vector Elite, Burlingame, 
California). Amino-ethylcarbazol was used for detection, and endogenous 
peroxidase was quenched in some instances following the primary antibody 
step by immersion in I % hydrogen peroxide in Tris-buffer. 
EBV DNA was detected in situ in formalin-fixed, paraffin-embedded tis-
sue using 35S autoradiography by the methods of Unger et al. (9) for pretreat-
ment and hybridization and of Weiss (10) for posthybridization washes. The 
EBV DNA probes were the two Bgt II/Bam HI fragments of the Bam HI-W 
repeat unit, radiolabeled with a 35S-aATP and aD~p-dCqm by the random 
primer technique. Controls consisted of known EBV -positive and negative 
tissues, and the use of radiolabeled plasmid DNA in place of probe. 
RESULTS 
Bacterial Translocation 
Bacterial translocation was documented in both patients. Serratia was cul-
tured on seven occasions from the blood of patient 1 during the first 12 post-
operative days, and Bacteroides was found in blood, pleural fluid and abdomi-
nal drainage in the first 4 days in patient 2. In both patients, Straphyiococci 
were thereafter found in the blood on occasion but without clinical evidence of 
sepsIs. 
The practical consequence of this phenomenon is that cholangitis was seen 
as an early feature in both children. Gram-negative bacteria were demonstra-
ble in the bile ducts in patient t, whereas cholangitis without demonstrable 
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organisms was seen on day 5 in patient 2. No bacteria were observed in a 
mesenteric lymph node sampled on day 5. In both instances the cholangitis 
had resolved, in the face of intensive antibiotic therapy, by day 17 or 18. 
Rejection 
Patient 1: Gastrointestinal Tract, Pancreas, and Liver. The donor co-
lon was subjected to biopsy at 6 days, 3 months and at 6 months and was 
essentially normal (Fig. 2a). At postmortem examination a range of epithelial 
preservation was revealed (Fig. 2b, c, d). Staining for intestinal alkaline phos-
phatase in the brush border of the jejunum revealed a normal microvillous 
distribution. Ganglion cells were present throughout the bowel, and the in-
trinsic nerves were not unduly conspicuous. Sections of the stomach revealed 
only that the donor epithelium was slightly lower than the recipient gastric 
mucosa. No cellular infiltrate was present on the donor side of the anastomo-
sis. The pancreas had very little interstitial fibrosis but patchy microcystic 
dilatations of pancreatic ducts were noted. The endocrine pancreas was intact; 
all cell types were represented in the islets. 
The bowel in general was depleted of lymphoid tissue; no solitary follicles 
or Peyer's patches were found. Immunostaining revealed only occasional 
UCH-l and immunoglobulin-containing cells in the lamina propria, far fewer 
than would be age-appropriate for this site. 
The liver, which had been biopsied on 15 separate occasions, had never 
displayed a pattern of cellular rejection, and at postmortem sampling none 
was evident. Steatosis and sinusoidal fibrosis was ascribed to parenteral hy-
peralimentation, and there was evidence of biliary obstruction. The major 
mesenteric vessels revealed no morphological changes. 
Rejection 
Patient 2: Gastrointestinal Tract, Pancreas, and Liver. The gastroin-
testinal tract, stomach, ileum, and colon were biopsied for the first time on 
day 24, 6 days after the patient had experienced a sharp and severe rise in 
bilirubin and had been treated empirically with OKT3 for rejection. The 
entire graft (the stomach, ileum, colon, and liver) showed evidence of mucosal 
rejection (Fig. 3). Lymphocytes were grown from a lymph node and the liver, 
and had strong reactivity against donor antigens. 
Frozen sections of the donor colon (Fig. 4) revealed, also on day 24, that 
the epithelium and most of the infiltrating cells expressed HLA-DR in large 
amounts. The predominant cells in the infiltrate were CD2 +, CD25 +, and 
CD4 > CD8 (after 6 days on OKT3), and the allospeci1ic sera highlighted the 
fact that donor sera (A2, BW6) stained residual epithelial and endothelial cells, 
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FIGURE 2. latestinaJ seclions, patient I. (a) Donor colon; biopsy al 6 months. The epithelium is intact; 
there is no ceBular infiltrate. X 2+0. (b) Donor jejunum; posunonem sample. Hyperplastic villi have intact 
epithelium. X120. (c) Donor midileum; postmonem sample; dystrophic changes. The mucosa has panial 
villus atrophy, and the submucosa is fibrotic; no cellular inftltrate is present. x 120. (d) Donor terminal 
ileum. The surface is lined by a single layer of "'generating columnar cells. The submucosa and muscularis 
arc scarred. X 120. 
but the inflltrating lymphoid cells had the recIpIent phenotype (HLA-25/32 
and HLA 24). Endoscopic biopsies of small bowel were performed 5 days later 
and, apart from more granulation tissue and macrophages, showed little dif-
ference from the preceding. 
The liver had previously been biopsied on day 18, when the cholangitis 
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FIGURE 3. Intestinal and liver sections, patient 2, da)· 24. (a) Donor stomach; rejection. The gastric 
mucosa is tall, but the deep glands are being destroyed by a ceUular inftltrate (a,.,ows). X 120. (b) Donor 
liver; rejection. The portal area is expanded by a mixed cellular infiltrate rich in lymphocytes and rosino-
phils. The hepatic lobule is relatively spared. x 280. (c) Donor, tenninal ileum; rejection. The mucosa is 
devoid of epithelium. A residual lymphoid follicle is re<:ognizable. The lamina propria is populated by 
lymphoid ceUs. X 160. (d) Donor colon; rejection. Damaged and regenerating glands and surface epithe-
lium are present. and an infiltrate separates the glands. X 160. 
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FIeURE f. Donor colon. frozen sections. patient 2. day 27. (a) Donor-specific antibody Bw6 stains 
epithelial and endothelial cells but not the cellular infIltrate. (b) Recipient specific antibody HLA 25/32 
give. a mirror image to (a); the infiltrating cells in the lamina propria are of recipient phenotype_ (c) 
HLA-DR staining reveals intense expression on epithelial as well as infiltrating cells. Surprisingly. some 
glands (arrow) are unstained. (d) Many of the infiltrating lymphoid cells bear CD25 (IL·2) receptors . 
x 220. 
was subsiding. It did not reveal cellular rejection, although lymphocytes 
grown from this biopsy exhibited strong alloreactivity against donor antigens. 
Rebiopsy after 6 days of OKT3 therapy, however, revealed a classical picture 
of partially treated cellular rejection (Fig. 3b). 
Frozen sections of liver revealed an increase in the intensity of HLA-DR 
and donor-specific HLA expression on bile duct cells from the first to the 
second biopsy, and an increase in CD2 + CD25 + infUtrating cells of recipient 
phenotype. 
The pancreas was sampled postmortem and was intact but infUtrated ex-
tensively with the lymphoproliferative process to be described. It was not 
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possible to detect cellular rejection in the presence of the heavy lymphoprolif-
erative infiltrate. 
Graft-versus-Host and Other Lymphoid Reactions 
In neither patient was graft-versus-host disease documented. The recipi-
ent colon and transient skin rashes were biopsied on two occasions in patient 
1, looking for evidence of graft-versus-host reaction. No morphologic features 
of graft-versus-host were found, and there was no epithelial damage to host 
epithelium; postmortem sampling did not disclose donor cells in the host colon 
or esophagus when the allospecific sera were used. Patient 2 had biopsies of 
the native colon at the same time that rejection was documented in the grafted 
colon. This material was used as control for the allospecific sera and failed to 
show donor cells or epithelial injury of any kind. Bone marrow was not in-
cluded in the postmortem sampling permit and was not examined. 
Mesenteric lymph nodes of donor origin were sampled at laparotomy be-
cause of their prominence on days 5, 13, 17, 24, and 33 in patient 2, and 
donor nodes from the mesentery were also sampled at the time of transplanta-
tion. The nodes revealed a progressive expansion of the paracortex, which 
pushed small follicles, devoid of germinal centers, up against the capsule (Fig. 
5a). The center of the paracortical expansion was filled with large, pale im-
munoblasts with prominent nucleoli, lymphoblasts with pale cytoplasm, and 
many dendritic interdigitating cells best demonstrated with antibody to S100 
(Fig. 5b). The periphery of the paracortical nodules had darker, large plasma-
cytoid cells. The medullary cords had plasma cells and lymphocytes, and the 
architectural landmarks were at all times clearly discernable. Frozen sections 
of lymph node on days 13, 17, and 24 showed that the paracortical expansion 
was predominantly T cell, CD2 + CD4 > CDS; almost all lymphoid cells 
were of recipient phenotype by day 13; only the cordallining cells and endo-
thelial cells preserved their donor HLA markers. 
Lymphoproliferative Disease 
Patient 1. Computed tomogram on day 91 revealed a Swiss-cheese ap-
pearance to the liver. Biopsy of the liver showed this to be a result of a cellular 
infiltrate composed almost entirely of plasmacytoid cells (Fig. 6). Frozen sec-
tions confirmed that kappa and lambda light chains were equally represented, 
and the cells stained for HLA-A3, not for Bw4, indicated that the proliferation 
was of probable host, not donor origin (Fig. 6b). UCH-l staining cells, 
mainly T cells, were conspicuous between the immunoglobulin-producing 
cells (Fig. 6c). The process was thought to represent a polymorphous (poly-
clonal) lymphoproliferative reaction, and this was liable to involution. 
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FIGURE 5. Donor m~s~nt~ric nod~I pati~nt 2, day U. (a) Mark~d paracortical expansion compresses the 
small follicles against the capsule. di~msaK X 160. (b) The exu~rant proliferation of interdigitating den· 
dritic cells is revealed in the paracortex by S-IOO staining. X 440. 
EBV nuclear antigen was detected in frozen sections of liver biopsy, and 
EBV DNA was demonstrated using DNA probes. Serology had previously 
demonstrated a rise of EBV IgG capsid antigen from 1 : 5 6 weeks before the 
diagnosis of lymphoproliferative disease, to 1 : 160 3 weeks before diagnosis. 
IgM anti-EB viral capsid antigen was less than 1 : 5 two weeks after diagnosis 
of the LPD. 
Immune suppression was stopped for 15 days, and the lesions underwent 
necrosis by a process that appeared to be infarction. No host T cells were 
observed in the necrotic tissue (Fig. 6d). The lesions shrunk over the next 
month and calcified at the periphery. For the next 2 months only necrotic 
lymphoproliferative disease was seen on four successive biopsies, but at 5 
months, the presence of active, viable lymphoproliferative disease coincided 
with the appearance of a new hilar lesion. The hilar lesion caused biliary 
obstruction; the obstruction became infected; the child became septic and 
died. 
Postmortem sampling revealed the old, calcified lesions and the new hilar 
mass (Fig. 7a). The hilar mass consisted largely of infarcted liver, but at the 
edges and core were large blood vessels with a perivascular (angiocentric and 
angioinvasive) infiltrate (Fig. 7b, c). The angiocentric cells were not plasma-
cytoid but pleomorphic (anaplastic) and could not be phenotyped. The lesion 
}. 
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FIGURE 6. Lymphoproliferative disease, patient I. (a) Biopsy of the liver at 91 days reveals a fairly 
uniform population of cells thaI obscure all rortallandmarks and spills over into the lobule. Giemsa, X 110. 
(b) The Iymphoproliferative reaction was of recipient phenotype. Recipient specific antibody (R) HLA-A3 
stains most cells, whereas the donor specific antibody (D) Bw4 leaves the cells unstained. X 200. (e) 
Although immunoglobulin cdls predominate, T cdls, as demonstrated by UCH-l, are well represented in 
the lesion. X 200. (d) The calcific tim is seen around the ghost cells of what appean to be infarcted 
Iymphoproliferative disease al day 137. X 180. 
was thought to be related to the more typical LPD because the two processes 
merged in places, but the identity of the vascular lesions remains cryptic. 
EBV was not demonstrated in the angiocentric lesions, and the host pheno-
type could not be confirmed. 
Sampling of other graft organs postmortem showed that the lymphoprolif-
erative process was confined to the mass in the hilus, but it extended contigu-
ously to a portion of colon adherent to the hilus and to the head of the pan-
creas, also in contiguity. In the pancreas, cells at the periphery of the reaction 
were plasmacytoid; those at the center had the anaplastic angiocentric appear-
ance seen best in the hilar mass. A host lymph node was sampled and was 
uninvolved. 
l ymphoproliferative Disease 
Patient 2. On day 33 after transplantation, only two days after prior 
exploration that had revealed cellular rejection, biopsies of the donor intes-
tine, liver, and lymph node revealed a diffuse lymphoproliferative disease. 
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Whereas the prior biopsies had shown epithelial destruction accompanied 
by a mixed cell infiltrate (Fig. 8a), the biopsy on day 33 had cohesive sheets of 
lymphoid cells with plasma cells, plasmacytoid cells, and large immunoblasts 
(Fig. 8b). There were few, if any, small lymphocytes, eosinophils, or neutro-
phils, and the cellular infiltrate now spilled over into the submucosa, obscur-
ing all landmarks. 
Immunostains documented IgM in most cells and an equal distribution of 
kappa and lambda light chains. Allospecific sera showed the infiltrate to be of 
host phenotype (Fig. 8c, d); by this test the lymphoproliferative infiltrate was 
not distinguishable from rejection. Lymphocytes cultured from this biopsy 
still had marked antidonor activity, revealing that cellular rejection, although 
no longer morphologically recognizable, was still in progress. 
Liver biopsy also differed from the previous specimen seen 9 days earlier 
in that a highly cellular portal infiltrate overran all architectural landmarks, 
spilling into the lobule, and the cells were the same as those seen in the gut. 
The lymph node differed from the one seen only 5 days before in that all 
architectural landmarks were obliterated by the diffuse proliferation (Fig. 9). 
Sinuses, cords, and follicles were no longer distinguishable. The cells in the 
lymph node marked as did those in the gut; IgM-predominated, kappa and 
lambda light chains were equally represented, and the infiltrate was of host 
phenotype. 
Sampling of host organs postmortem was limited to a lymph node and 
kidney. Diffuse infiltration by the lymphoproliferative process was present in 
both of these (Fig. 9). Donor and recipient lymph nodes were indistinguish-
able except for the greater amount of lipochrome and bile pigment in the host 
lymph nodes (Hamazaki-Wesenberg bodies). 
EBV DNA was detected in large amounts in wide distribution in the node 
on day 33, but only in rare cells in the follicles on day 17 (Fig. 10). All other 
viral cultures, specifically for cytomegalovirus and adenovirus, were consls' 
tently negative in both patients. 
DISCUSSION 
Morphologic monitoring remains a mainstay after transplantation of vari-
ous organs such as kidney or liver, even though there is an accumulated 
clinical experience that now stretches back over decades. When faced with an 
experimental clinical situation, such as the one we are describing, the patholo-
gist is placed in an uncomfortable position; the transplant team is forced to 
resort to biopsy for clinical monitoring, yet there is no prior experience on 
which pathologists can base their diagnostic decisions. The 2 cases presented 
here, bolstered by functional studies in patient 2, have allowed us to describe 
the morphologic appearances of a number of clinical events. 
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FIGURE 8. Lymphoproliferative disease, patient 2. (a) Donor ileum, day 24; rejection. Severe cellular 
rejection is represented. Fragments of residual epithelium are seen, and a mixed cellular infiltrate is pre-
sented in the lamina propria_ x 160_ (b) Donor ileum, day 34; lymphoproliferative disease. The infiltrate is 
more exuberant, more monotonous, the cells are larger, and the inftltrate obscures anatomic boundaries 
such as the muscularis mucosae_ x 160_ (c) Ileum, day 34. Frozen section stained with donor specific 
antibody Bw6 stains endothelial cells and epithelial remnant •. X 300. (d) An adjacent section stained with 
recipient·speciflC antibody HLA 25/32 Illghlights the inftltrating lymphoid ceUs_ The pattern does not 
distinguish rejection (see Fig. 4) from the Iymphoproliferative process. X 300. 
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The entire spectrum of graft rejection was represented. One patient had 
no documented rejection; the second had severe and profound cellular rejec-
tion involving intestine and to a lesser extent the liver. The biopsy diagnosis of 
rejection in the intestine was based on the following three criteria; the similar-
ity of the rejection reaction to that described in other solid organs such as 
kidney and liver (11, 12), the similarity of the reaction to that described in 
animal models of small intestinal transplantation (13, 14), and by the confir-
FIGURE 9. Lymphoproliferative disuse; donor mesenteric lymph node. day 34, patient 2 (compare with 
day 24, Fig. 5). (a) Whereas the lymph node previously demonstrated an expanded paraconex. the lymph 
node architecture is now effaced by a diffuse lymphoid proliferation. X 120. (b) The proliferation is poly· 
morphous; lymphocytes, plasma cells. plasmacytoid cells. and immunoblasu are represented. Giemsa. 
X 660. (c) Donor lymph node. day 34 (see Fig. 9). Most of the immunoglobulin·containing cells stain for 
IgM. Kappa and lambda chains were equally represented. fmmunoperoxid~K X 160. (d) The Iymphopro· 
liferative process was not confined to donor organs, being seen here in the ho!! kidney. X 280. (e) 
Recipient·specific antibody stains almost all infiltrating cells but not endothelium or sinus lining cells. 
Frozen seerion, immunopcroxidase X 300. (I) Donor·specific antibody Bw6 stains sinus lining cells. endo· 
thdial ceils, and occasional large (po!l.Slbly dendritic) cells. X 300. 
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FIGURE 10. (a) Donor mesenteric lymph node at day 17. J5S label for EBV DNA is seen in a lymphoid 
foUide (4fTow). (The large black object at center is anefact.) X 200. (b) Donor me~nteric lymph node at 
day H. There is now diffuse labeling for EBV DNA of many cells throughout the node. X 200. 
mation obtained from the alloreactivity exhibited by lymphocyte cultures 
propagated from multiple liver biopsies and a single ileal biopsy (6). 
Functional studies of lymphocytes grown from biopsies were used to gain 
confidence in the morphologic diagnosis of rejection. Although the cells that 
grow from the biopsies are a selected population of activated T cells, the 
correlation between morphology and antidonor reactivity of the alJoreactive 
cells has been demonstrated in cardiac biopsies (15). Also, antidonor alloreac-
tivity has been shown to predict rejection in a subsequent biopsy when the 
ceJJs are grown from a biopsy that fails [0 reveal cellular rejection (16). This 
was demonstrated in the liver biopsy of patient 2 on day 17 when only resolv-
ing cholangitis was seen, but on day 24 classical rejection was observed. It also 
indicated to us, although we could not see it, that in the biopsy of the ileum 
demonstrating lymphoproliferative disease (Fig. 8), cellular rejection was oc-
curring simultaneously. 
The features of cellular rejection appear to include a cellular infUtration of 
the lamina propria with a mixed cell inftltrate; the effector cells are activated 
T-cells, CD2 + CD25 +, and intermixed with these are eosinophils, neutro-
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phils, and monocyte-macrophages. HLA-DR hyperexpression is present on 
epithelium. 
~ Teitelbaum et al. (l4), using a rat model, make a number of important 
V points that are pertinent here. Early villus destruction was seen after reperfu-
sion, and this regenerates very rapidly within 2 days. When cellular rejection 
supervenes (day 6 in their model), the effect is seen first in the cryE.!! with 
crypt cell damage leading to villus blunting and later, by 10 days, to mucosal 
destruction. Biopsy of the stomach in our patient 2 showed in similar fashion 
that the surface mucosa was quite intact but that the deep glands were se-
verely damaged. Dilated lymphatics, which might have been anticipated be-
cause of interference with lymphatic connections, were never a feature. Teitel-
baum et al. (H) warn that chronic ischemia, malnutrition, and enteritis in 
their model may produce histologic changes that mimic rejection. Caution in 
the interpretation of histologic changes is always prudent, but the characteri-
zation of the infIltrate as activated T cells, as in our patients, lends support to 
the diagnosis of rejection. Teitelbaum et al. (14) also point to the patchiness of 
their findings, suggesting that multiple biopsies should be performed at any 
procedure to prevent overlooking focal involvement. Our diagnostic biopsies 
in patient 2 were taken when the process was already advanced, so that 
changes were seen in all fragments, even though there was some variation in 
the amount of residual epithelium. This corresponds to the phase III rejection IJI ,.,. response described by Rosemuri}' and Schraut (17), who were convinced that 
rejection in their rat model followed a defined and predictable morphologic 
- course. 
There has been debate over the adequacy of mucosal biopsy for the moni-
toring of small bowel rejection in animal models. Some authors claim that 
only full-thickness biopsy is reliable and that mucosal biopsies are unreliable 
(18, 19). Cohen et al. (20) found mucosal biopsies to be adequate, and Ma-
dara and Kirkman (21), in an elegant morphometric study, suggested that a 
mucosal microvascular lesion was the most characteristic. There does not 
seem to be an alternative to mucosal biopsy in humans, and the observations 
of Goulet et al. (3), as well as our own, reveal that mucosal biopsy, using the 
criteria previously described, is sufficient for the monitoring of rejection. The 
differential diagnosis of rejection from viral infection in a mucosal biopsy may 
still be difficult. 
The effect of changes in immune suppression on the. morphologic appear-
ance of rejection, whether by augmentation of doses or by a change in the 
kinds of medications used, remains to be elucidated. We are mindful of the 
fact that our patients (or their grafts) had received, at one time or another, 
cycJosporine A, azathroprine, solumedrol, solucortef, anti thymocyte globulin, 
OKT3, and irradiation. 
Graft-versus-host disease (GVHD) has been of major concern since multi-
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pie visceral transplantation was first considered (22). In animal models of 
small bowel transplantation, the baJance achieved between rejection on one 
hand, and graft-versus-host disease on the other is weU demonstrated (23-26). 
Irradiation of the donor small bowel in rats abolished GVHD, but rejection 
was then more severe (27). In our first patient the graft was irradiated, there 
was no evidence of GVHD, and no rejection was demonstrated. In the second 
patient the graft was not irradiated, and there was no evidence of GVHD, but 
severe rejection occurred. It is likely that in humans, following multivisceral 
transplantation, GVHD and rejection can be modulated independently. 
The definitive diagnosis of GVHD requires evidence of donor lymphoid 
engraftment and damage to host tissues. In the clinical situation, when there 
is no damage to host tissues (skin, native gastrointestinal tract, lung, or bone 
marrow), the pathologist may not pursue the search for cells of donor origin. 
Skin and esophagus showed no morphological evidence of GVH. We used 
allospecific sera on native colon and kidney to look for evidence of donor cell 
infiltration even in the face of a normal epithelium, but none was found. 
Donor engraftment in host lymph nodes and bone marrow was not sought in 
these 2 cases. 
In the animal models of small bowel transplantation, rejection is associ-
ated with small and involuted lymph nodes, and graft-versus-host disease with 
the finding of large infiltrated mesenteric nodes (23-26). The morphologic 
pattern of paracortical expansion seen in successive samples of enlarging mes-
enteric nodes from patient 2, during periods of rejection, was associated with 
rapid replacement within 17 days of virtually all donor lymphoid cells by those 
of host origin. Only the sinusoidal lining cells, endothelial cells, and possibly 
some dendritic cells, retained the donor phenotype. We therefore interpreted 
the increase in paracortical cellularity in the mesenteric nodes as a hyperplas-
tic reaction, much in the sense of a mixed lymphocyte culture, and not as a 
graft versus host reaction. \\'hether it represents the nodal manifestation of 
rejection we are not able to say, although propagated cells demonstrated 
strong antidonor reactivity. 
Both patients developed a lymphoproliferative syndrome associated with 
EBV infection. In both instances the proliferation was polymorphous and 
plasmacytoid, polydonal or polytypic by light chain assay (28), and confined 
to the liver in patient 1 but more systemic in patient 2. The puzzling nature of 
the terminal vasculitic and anaplastic lesion in patient 1 was never fully eluci-
dated but may represent lymphomatous transformation of the LPD. We agree 
with Colby (29) that designating this angiocentric Iymphomalike process as 
lymphomatoid granulomatosis is unhelpful in understanding its nature. 
Lymphoproliferative disease was diagnosed on biopsy by the B-cell nature 
of the infiltrate, its plasmacytoid character, and by the absence of the pleocy-
totic infthrate characteristic of rejection (28). The allospecific sera were of no 
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assistance, since the lymphoproliferative reaction, like rejection, was of host 
origin. Likewise the lymphocyte cultures grown from the allograft biopsies 
taken at the time of active Iymphoproliferative disease still showed some anti-
donor activity indicating that the Iymphoproliferative disease masks some on-
going cellular rejection. A similar event is described by Williams et al. (2), 
although the lymphoproliferative disorder in their multivisceral recipient was 
monoclonal. 
Resolution of the lymphproliferative disorder in patient 1 was by a process 
that appears to be infarction of the lymphoid tissue. A similar process is 
observed in lymphoproliferative disorders involving Waldeyer's ring in which 
extensive necrosis of tissue is common, often associated with thrombosis in 
high-walled venules (28). A small amount of venous thrombosis was seen in 
the liver. We assume that vascular endothelial swelling and proliferation, 
which is prominent during active EBV infection, involutes and regresses with 
thrombosis and tissue infarction as the viral infection passes. Local monokines 
may regulate these vascular effects, but the morphology of the involuting 
lesion does not support the idea that host cytotoxicity plays a major role. 
There is very little inflammatory response to the infarcted lymphoid prolifera-
tion, and regression is by granulation and macrophage activity from the pe-
riphery. 
The intestine loses its impermeability to bacteria after being subjected to 
the ischemia associated with transplantation (30). Bacterial translocation, as 
the process is referred to, involves migration of endogeneous flora across the 
now permeable bowel into the lacteals then the blood. The same microorgan-
isms that are found in the blood of these patients are found 1 or 2 days in 
advance in the stool (1). In general the bacterial translocation was not associ-
ated with clinical sepsis other than the bacterial cholangitis early on in patient 
1. This was an unexpected finding, since the multivisceral operation, unlike a 
liver transplant, does not involve a biliary anastomosis. 
There are a number of ~s th~Kv;KgK We are able, we 
believe, to recognize the broad outlines of the immunologic processes, rejec-
tion, graft-versus· host disease, and the complication of Iymphoproliferative 
disease. When these processes are present simultaneously we may not be able 
to determine the relative proportions or importance of each. We do not know 
the effect of the various immunologic manipulations on the tissue expression; 
for example the administration of OKT3, steroid bolus therapy, azathioprine, 
and changes in cyclosporine levels may have effects that we have not antici-
pated. Numerous other drugs are given in concert, antibiotics, antiviral 
agents, antihypertensives, and these may have toxic as well as their antici-
pated therapeutic effects. We were able to detect hyperalimentation effect in 
the liver in patient 1. Superimpose on the above the effects of the bacteremias 
that follow bacterial translocation, and the pathologist has a formidable task. 
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We recommend that protocol sampling of the various organs be part of the 
monitoring of experimental transplantation procedures; this is a learning pro-
cess for everyone concerned, not least the pathologist. 
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